Cargando…
Impact of ERK5 on the Hallmarks of Cancer
Extracellular signal-regulated kinase 5 (ERK5) belongs to the mitogen-activated protein kinase (MAPK) family that consists of highly conserved enzymes expressed in all eukaryotic cells and elicits several biological responses, including cell survival, proliferation, migration, and differentiation. I...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471124/ https://www.ncbi.nlm.nih.gov/pubmed/30901834 http://dx.doi.org/10.3390/ijms20061426 |
_version_ | 1783411956440367104 |
---|---|
author | Stecca, Barbara Rovida, Elisabetta |
author_facet | Stecca, Barbara Rovida, Elisabetta |
author_sort | Stecca, Barbara |
collection | PubMed |
description | Extracellular signal-regulated kinase 5 (ERK5) belongs to the mitogen-activated protein kinase (MAPK) family that consists of highly conserved enzymes expressed in all eukaryotic cells and elicits several biological responses, including cell survival, proliferation, migration, and differentiation. In recent years, accumulating lines of evidence point to a relevant role of ERK5 in the onset and progression of several types of cancer. In particular, it has been reported that ERK5 is a key signaling molecule involved in almost all the biological features of cancer cells so that its targeting is emerging as a promising strategy to suppress tumor growth and spreading. Based on that, in this review, we pinpoint the hallmark-specific role of ERK5 in cancer in order to identify biological features that will potentially benefit from ERK5 targeting. |
format | Online Article Text |
id | pubmed-6471124 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-64711242019-04-26 Impact of ERK5 on the Hallmarks of Cancer Stecca, Barbara Rovida, Elisabetta Int J Mol Sci Review Extracellular signal-regulated kinase 5 (ERK5) belongs to the mitogen-activated protein kinase (MAPK) family that consists of highly conserved enzymes expressed in all eukaryotic cells and elicits several biological responses, including cell survival, proliferation, migration, and differentiation. In recent years, accumulating lines of evidence point to a relevant role of ERK5 in the onset and progression of several types of cancer. In particular, it has been reported that ERK5 is a key signaling molecule involved in almost all the biological features of cancer cells so that its targeting is emerging as a promising strategy to suppress tumor growth and spreading. Based on that, in this review, we pinpoint the hallmark-specific role of ERK5 in cancer in order to identify biological features that will potentially benefit from ERK5 targeting. MDPI 2019-03-21 /pmc/articles/PMC6471124/ /pubmed/30901834 http://dx.doi.org/10.3390/ijms20061426 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Stecca, Barbara Rovida, Elisabetta Impact of ERK5 on the Hallmarks of Cancer |
title | Impact of ERK5 on the Hallmarks of Cancer |
title_full | Impact of ERK5 on the Hallmarks of Cancer |
title_fullStr | Impact of ERK5 on the Hallmarks of Cancer |
title_full_unstemmed | Impact of ERK5 on the Hallmarks of Cancer |
title_short | Impact of ERK5 on the Hallmarks of Cancer |
title_sort | impact of erk5 on the hallmarks of cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471124/ https://www.ncbi.nlm.nih.gov/pubmed/30901834 http://dx.doi.org/10.3390/ijms20061426 |
work_keys_str_mv | AT steccabarbara impactoferk5onthehallmarksofcancer AT rovidaelisabetta impactoferk5onthehallmarksofcancer |